| James Frenette, MD | |
|
25 Hospital Dr, Bridgton, ME 04009-1156 | |
| (207) 795-5709 | |
| Not Available |
| Full Name | James Frenette |
|---|---|
| Gender | Male |
| Speciality | Orthopaedic Surgery |
| Location | 25 Hospital Dr, Bridgton, Maine |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1114999448 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207X00000X | Orthopaedic Surgery | 013478 (Maine) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| James Frenette, MD 25 Hospital Dr, Bridgton, ME 04009-1156 Ph: (207) 795-5709 | James Frenette, MD 25 Hospital Dr, Bridgton, ME 04009-1156 Ph: (207) 795-5709 |
News Archive
There are no scientific studies showing that lymphedema can be prevented, but there are ways to lower your risk of developing this treatment side effect. During the 10th Annual Conference for Young Women Affected by Breast Cancer, we will explore the myths and recent scientific evidence about lymphedema, learn about risk reduction techniques and discuss approaches to lymphedema management, including exercise, physical therapy, lymphatic drainage, massage and other treatment methods.
Two experimental brain-machine technologies - deep brain stimulation coupled with physical therapy and a thought-controlled computer system-may offer new therapies for people with stroke and brain injuries, new human research shows. In addition, an animal study shows a new artificial retina may restore vision better than existing prosthetics. The findings were announced today at Neuroscience 2010, the annual meeting of the Society for Neuroscience and the world's largest source of emerging news on brain science and health.
This post in the Center for Global Health Policy's "Science Speaks" blog reports on a presentation at the Union World Conference on Lung Health in France on Saturday by Evelyne Kibuchi, a senior tuberculosis (TB) advocacy officer at the Kenya AIDS NGOs Consortium (KANCO), writing, "HIV stakeholders have been slow to embrace and adopt TB interventions, Kibuchi said, and resources for co-infection activities are modest.
Advaxis, Inc.,, a leader in developing the next generation of immunotherapies for cancer and infectious diseases, has entered into a definitive Convertible Notes Purchase Agreement (Agreement) with certain accredited investors, for the purchase of the aggregate principal value of approximately $1.2 million of Convertible Promissory Notes (Notes) for an aggregate purchase price of approximately $1.0 million.
Pregnancy complications affect up to one in three pregnancies and are increasingly linked to future chronic disease.
› Verified 5 days ago
Dr. Dennis J Sullivan, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 55 Main St., Suite 2, Bridgton, ME 04009 Phone: 207-647-3633 Fax: 207-647-5633 |